← Back to Patent Explorer
US4138475A Expired / Lapsed US ⏱️ 0.0 years remaining

Sustained release pharmaceutical composition

Assignee: Syngenta Ltd
•
Filing: 1977-09-14
•
Granted: 1979-02-06
•
Expires: 1997-09-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Sustained release pharmaceutical composition consisting of a hard gelatine capsule containing film coated spheroids, the spheroids comprising propranolol, or a pharmaceutically-acceptable salt thereof, in admixture with non-water-swellable microcrystalline cellulose, and the said spheroids having a film coat comprising ethylcellulose optionally together with hydroxypropyl methylcellulose and/or a plasticizer.

Inventors

  • 👤 James McAinsh
  • 👤 Raymond C. Rowe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:44
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135; A61K9/00; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5036; A61K9/5042; A61K9/5047; A61P; A61P25/00; A61P25/02

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 56 words
A sustained release pharmaceutical composition consisting of a hard gelatine capsule containing film coated spheroids, the said spheroids comprising, prior to coating, 40 to 65% by weight of propranolol, or a pharmaceutically-acceptable acid-addition salt thereof, in admixture with non-water-swellable microcrystalline cellulose, and the said spheroids having a film coat comprising ethylcellulose or ethycellulose and hydroxpropyl methylcellulose.
Claim 2
Dependent Claim 56 words
A sustained release pharmaceutical composition consisting of a hard gelatine capsule containing film coated spheroids, the said spheroids comprising, prior to coating, 40 to 65% by weight of propranolol, or a pharmaceutically-acceptable acid-addition salt thereof, in admixture with non-water-swellable microcrystalline cellulose, and the said spheroids having a film coat comprising ethylcellulose or ethycellulose and hydroxpropyl methylcellulose.
Claim 3
Dependent Claim 31 words
The composition claimed in claim 1 in which the uncoated spheroids contain 50 to 60% by weight of propranolol hydrochloride and 50 to 40% by weight of non-water-swellable microcrystalline cellulose, respectively.
Claim 4
Dependent Claim 21 words
The composition claimed in claim 1 in which the film coat comprises 5 to 15% by weight of the coated spheroids.
Claim 5
Dependent Claim 19 words
The composition claimed in claim 1 in which the ethylcellulose has a viscosity of 50 cps at 20° C.
Claim 6
Dependent Claim 20 words
The composition claimed in claim 1 in which the hydroxypropyl methylcellulose has a viscosity of 6 cps at 20° C.
Claim 7
Dependent Claim 28 words
The composition claimed in claim 1 in which the film coat comprises 80 to 100% by weight of ethylcellulose and 20 to 0% by weight of hydroxypropyl methylcellulose.
Claim 8
Dependent Claim 20 words
The composition claimed in claim 1 in which the film coat contains up to 20% by weight of a plasticizer.
Claim 9
Dependent Claim 20 words
The composition claimed in claim 1 which contains 100 to 200 mg. of propranolol or a pharmaceutically-acceptable acid-addition salt thereof.
Claim 10
Dependent Claim 92 words
The composition claimed in claim 1 in which, prior to coating, the spheroids contain 60% by weight of propranolol hydrochloride in admixture with 40% by weight of non-water-swellable microcrystalline cellulose, and the spheroids have a film coat consisting of 90% by weight of ethylcellulose having a viscosity of 50 cps at 20° C. and 10% by weight of hydroxypropyl methylcellulose having a viscosity of 6 cps at 20° C., the film coat comprising 9 to 10% by weight of the coated spheroids, and the said composition containing 160 mg. of propranolol hydrochloride.

References Cited (Backward Citations)

US2853420A Cited
US2921883A Cited
US2887440A Cited
US2928770A Cited
US3146168A Cited
US3247066A Cited
US3400185A Cited
US3492397A Cited
US3835221A Cited
US3917813A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-02-05 1982-08-07 1983-02-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-02-05 1986-08-07 1987-02-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-02-05 1990-08-07 1991-02-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag